Price at ₹1,292.70 is 5.3% above rising 200 SMA (₹1,227.63).
Q4 profit missed estimates due to lower treasury income and higher provisions.
Kevin Warsh nomination may lead to rate cuts, boosting EM inflows.
Revenue CAGR ~12% (FY23-26); net income tripled to ₹26,385 Cr.
Stock dropped 4.8% on April 27 after ₹17,000 Cr dilution announcement.
P/E ~10x, PEG 0.54 vs FY26 net income down 6% YoY.
PEG of 0.54 and forward P/E under 10 suggest cheap valuation.
Price at 15x TTM earnings, 5.3% above rising 200-day SMA (₹1,227).